A cell-based assay, also known as a cellular assay, is a scientific technique used to assess the effects of various substances on living cells. It plays a crucial role in fields such as biology, pharmacology, toxicology, and drug development. Cell-based assays are designed to measure a wide range of cellular processes, including cell viability, proliferation, apoptosis (cell death), and various biochemical or physiological functions within cells.   

The pharmaceutical and biotechnology industries remain major drivers of the cell-based assay market. The need for more efficient and accurate drug screening, lead optimization, and toxicity testing will continue to propel cell-based assay market growth. Ongoing advances in automation, high-content screening, 3D cell culture, and live-cell imaging are enhancing the capabilities and efficiency of cell-based assays. These innovations will drive adoption across various research fields.      

The report “Cell-Based Assay Market, By Product (Instruments, Reagents and Assay Kits, Cell Lines, Software, Microplates, and Others), By Application (Predictive Toxicology, Drug Discovery, ADME Process, and Others), By End-User (Research Organizations, Pharmaceutical companies, Government & Academic Institutes, Biotechnology Companies, and Other end-users) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In June 2021, LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, launched a new Cell-Based Assay Service following the acquisition of biotechnology firm IONTOX. These unique in vitro screening options extend LifeNet Health's commitment to improving lives through the gift of donation, while also offering safer, more effective alternatives to animal testing for novel compound discovery. They also bring a new degree of predictability and relevance to humans.

Analyst View:

Robust cell-based assays are essential for the development and quality control of cellular therapies and tissue engineering applications in regenerative medicine and stem cell therapies. Cell-based assays are essential for determining whether items and chemicals are safe, and they have helped the business expand in sectors including environmental monitoring and toxicology.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Cell-Based Assay Market, By Product (Instruments, Reagents and Assay Kits, Cell Lines, Software, Microplates, and Others), By Application (Predictive Toxicology, Drug Discovery, ADME Process, and Others), By End-User (Research Organizations, Pharmaceutical companies, Government & Academic Institutes, Biotechnology Companies, and Other end-users) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Cell-Based Assay Market accounted for US$ 20.9 billion in 2024 and is estimated to be US$ 61.3billion by 2034 and is anticipated to register a CAGR of 12.6%. Cell-Based Assay Market is segmented based on Product, Application, End-User and Region.

• Based on Product, Cell-Based Assay Market is segmented into Instruments, Reagents and Assay Kits, Cell Lines, Software, Microplates, and Others.
• Based on Application, Cell-Based Assay Market is segmented into Predictive Toxicology, Drug Discovery, ADME Process, and Others.
• Based on End-User, Cell-Based Assay Market is segmented into Research Organizations, Pharmaceutical companies, Government & Academic Institutes, Biotechnology Companies, and Other end-users.
• By Region, the Cell-Based Assay Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Cell-Based Assay Market:

The prominent players operating in the Cell-Based Assay Market includes, Cisbio Bioassays, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., cell Signaling Technology, Inc., Merck & Co., Bio-Rad Laboratories, Charles River Laboratories, Promega Corporation, Lonza Group AG, and Hoffmann-La Roche Ltd.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com